Two Sigma Advisers’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $113K | Sell |
16,340
-19,800
| -55% | -$137K | ﹤0.01% | 2197 |
|
2025
Q1 | $192K | Buy |
36,140
+25,113
| +228% | +$133K | ﹤0.01% | 2146 |
|
2024
Q4 | $130K | Buy |
+11,027
| New | +$130K | ﹤0.01% | 2187 |
|
2022
Q4 | – | Sell |
-560
| Closed | -$3K | – | 2544 |
|
2022
Q3 | $3K | Buy |
+560
| New | +$3K | ﹤0.01% | 2509 |
|
2022
Q2 | – | Sell |
-467
| Closed | -$7K | – | 2692 |
|
2022
Q1 | $7K | Buy |
467
+90
| +24% | +$1.35K | ﹤0.01% | 2706 |
|
2021
Q4 | $7K | Buy |
+377
| New | +$7K | ﹤0.01% | 2583 |
|
2021
Q3 | – | Sell |
-1,333
| Closed | -$73K | – | 2474 |
|
2021
Q2 | $73K | Sell |
1,333
-7,620
| -85% | -$417K | ﹤0.01% | 2365 |
|
2021
Q1 | $529K | Buy |
8,953
+7,416
| +482% | +$438K | ﹤0.01% | 2004 |
|
2020
Q4 | $58K | Buy |
+1,537
| New | +$58K | ﹤0.01% | 2307 |
|
2020
Q3 | – | Sell |
-1,737
| Closed | -$437K | – | 2435 |
|
2020
Q2 | $437K | Buy |
+1,737
| New | +$437K | ﹤0.01% | 1953 |
|
2020
Q1 | – | Sell |
-447
| Closed | -$73K | – | 2476 |
|
2019
Q4 | $73K | Sell |
447
-260
| -37% | -$42.5K | ﹤0.01% | 2273 |
|
2019
Q3 | $103K | Buy |
+707
| New | +$103K | ﹤0.01% | 2112 |
|